Avidity Biosciences, Inc. (RNA)
71.43
+0.13
(+0.18%)
USD |
NASDAQ |
Dec 10, 12:08
Avidity Biosciences EPS Diluted (Quarterly): -1.265 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Novartis AG | 2.020 |
| Eli Lilly & Co. | 6.211 |
| Dyne Therapeutics, Inc. | -0.7619 |
| Astria Therapeutics, Inc. | -0.5455 |
| Intellia Therapeutics, Inc. | -0.9196 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -174.44M |
| Revenue (Quarterly) | 12.48M |
| Total Expenses (Quarterly) | 186.92M |
| Enterprise Value | 8.917B |
| Gross Profit Margin (Quarterly) | 91.54% |
| Profit Margin (Quarterly) | -1.40K% |
| Earnings Yield | -5.84% |
| Normalized Earnings Yield | -5.838 |